MedPath

广东人人康药业有限公司

Ownership
-
Established
1993-01-08
Employees
-
Market Cap
-
Website
http://www.reekon.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

NMPA:16

Drug Approvals

Domperidone Orally Disintegrating Tablets

Product Name
多潘立酮口腔崩解片
Approval Number
国药准字H20090246
Approval Date
Apr 15, 2024
NMPA

Compound Camphor Cream

Product Name
复方樟脑乳膏
Approval Number
国药准字H20084007
Approval Date
Apr 2, 2024
NMPA

Meloxicam Tablets

Product Name
清轻
Approval Number
国药准字H20030644
Approval Date
Dec 6, 2019
NMPA

Acetylcysteine Capsules

Product Name
易维适
Approval Number
国药准字H20000519
Approval Date
Dec 3, 2019
NMPA

Hydroquinone Cream

Product Name
千白
Approval Number
国药准字H20040088
Approval Date
Dec 3, 2019
NMPA

Meloxicam Capsules

Product Name
美洛昔康胶囊
Approval Number
国药准字H20030643
Approval Date
Nov 21, 2019
NMPA

Glipizide Tablets

Product Name
格列吡嗪片
Approval Number
国药准字H10983109
Approval Date
Nov 21, 2019
NMPA

Hydroquinone

Product Name
氢醌
Approval Number
国药准字H20040084
Approval Date
Nov 21, 2019
NMPA

好样牌助眠口服液

Approval Number
国食健字G20050626
Approval Date
Feb 3, 2015
NMPA

望睡牌助眠口服液

Approval Number
国食健字G20041375
Approval Date
Dec 6, 2004
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy